Rezapour, J. http://orcid.org/0000-0002-4596-6947
Nickels, S.
Schuster, A. K.
Michal, M.
Münzel, T.
Wild, P. S.
Schmidtmann, I.
Lackner, K.
Schulz, A.
Pfeiffer, N.
Beutel, M. E.
Funding for this research was provided by:
Stiftung Rheinland-Pfalz für Innovation (AZ 961-386261/733)
Center for Translational Vascular Biology
Boehringer Ingelheim Stiftung
PHILIPS Medical Systems
Novartis Pharma
Bundesministerium für Bildung und Forschung (BMBF 1EO1003)
Article History
Received: 3 April 2018
Accepted: 20 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: The Gutenberg Health Study was approved by the ethics committee (Ethics Commission of the State Chamber of Physicians of Rhineland-Palatinate, reference no. 837.020.07, original vote: 22.3.2007, latest update: 20.10.2015). According to the Declaration of Helsinki, written informed consent was obtained from all subjects before entering the study.
: Not applicable
: The authors declare that they have no competing interests.Boehringer Ingelheim, PHILIPS Medical Systems and Novartis Pharma provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the BMC Ophthalmology policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.